[{"NetIncomeLoss_1_Q1_USD":-16514000.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q1_USD":-0.66,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":4539000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-189000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":18000000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":12411000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":1180000.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q1_shares":24844946.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":17000.0,"AssetsCurrent_0_Q1_USD":102606000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":2060385.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":121000.0,"AvailableForSaleSecurities_0_Q1_USD":96247000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":2687000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":96247000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":24844946.0,"Assets_0_Q1_USD":105924000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4012000.0,"MarketableSecuritiesCurrent_0_Q1_USD":73686000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":-218000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":-841000.0,"CommonStockValue_0_Q1_USD":2000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":362000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":14168000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-38000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1301000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":28372000.0,"DeferredRevenueNoncurrent_0_Q1_USD":983000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-16526000.0,"OtherAssetsNoncurrent_0_Q1_USD":389000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":24720000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":323184000.0,"Liabilities_0_Q1_USD":14283000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-50000.0,"DepreciationAndAmortization_1_Q1_USD":280000.0,"ShareBasedCompensation_1_Q1_USD":2687000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":5304096.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":1180000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":19000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-16514000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":38000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-13910000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":82079000.0,"WorkersCompensationLiabilityCurrent_0_Q1_USD":2167000.0,"LiabilitiesCurrent_0_Q1_USD":11143000.0,"DeferredRevenueCurrent_0_Q1_USD":3135000.0,"AccountsPayableCurrent_0_Q1_USD":3131000.0,"NonoperatingIncomeExpense_1_Q1_USD":47000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4200000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":121000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":64000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":24720000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2929000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":7362000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":15734000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-198000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":112000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1222000.0,"OperatingIncomeLoss_1_Q1_USD":-16561000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":105924000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2687000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":10291000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":13771000.0,"OperatingExpenses_1_Q1_USD":17783000.0,"ProfitLoss_1_Q1_USD":-16514000.0,"OtherLiabilitiesCurrent_0_Q1_USD":338000.0,"StockholdersEquity_0_Q1_USD":91641000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":227000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":96245000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":2157000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-231356000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.66,"AccruedProfessionalFeesCurrent_0_Q1_USD":248000.0,"Ticker":"RAPT","CIK":"1673772","name":"RAPT THERAPEUTICS, INC.","OfficialName":"RAPT Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"595076458.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210511"}]